Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation.

Abstract

Myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and a variable propensity for leukemic transformation. In recent years there has been an explosion of information on the molecular genetic changes underlying these disorders. This information has… (More)
DOI: 10.14694/EdBook_AM.2015.35.e398

Topics

3 Figures and Tables

Cite this paper

@article{Odenike2015MyelodysplasticSA, title={Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation.}, author={Olatoyosi M. Odenike and Francesco Onida and Eric Padron}, journal={American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting}, year={2015}, pages={e398-412} }